Chang Carmen
Director, 10% owner at NEUE; Director at COUR; 10% owner at GENOCEA BIOSCIENCES, INC., and 2 more
- Sold, on record
- $1.3M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Oct 2, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 5
- Filed as an executive or holder
Companies
- NEUENeueHealth, Inc.Director, 10% owner
- COURCoursera, Inc.Director
- GENOCEA BIOSCIENCES, INC.10% owner
- Metacrine, Inc.10% owner
- TRVITrevi Therapeutics, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- GENOCEA BIOSCIENCES, INC.10.4M shares
- Metacrine, Inc.497,270 shares
- NEUE3,915 shares
- COUR1,226 shares
- TRVI564 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TRVIPlan not statedApr 3 2020
Sold 564 shares at $2.66 ($2k)
Chang Carmen, 10% owner
Sold 0% of holdings ($15.8M position)5.9M shares leftFirst sale on recordFiling
- 2 Form 4 sale Metacrine, Inc.Plan not statedDec 22 +628 days
Sold 497,270 shares at $0.99 ($494k)
Chang Carmen, 10% owner
Sold 16.2% of holdings ($3M position)2.6M shares leftFirst sale on recordFiling
- 3 Form 4 sale GENOCEA BIOSCIENCES, INC.UnusualMay 25 +154 days
Sold 10.4M shares at $0.0743 ($771k)
Chang Carmen, 10% owner
Sold 100% of holdings ($771k position)0 shares leftFirst sale on recordFiling
- 4 Form 4 sale COURPlan not statedMar 15 +294 days
Sold 1,226 shares at $11.82 ($14k)
Chang Carmen, Director
Sold 3.7% of holdings ($388k position)31,640 shares leftFirst sale on recordFiling
- 5 Form 4 sale NEUENo planOct 2 +932 days
Sold 3,915 shares at $6.75 ($26k)
Chang Carmen, Director, 10% owner
No 10b5-1 planSold 0.2% of holdings ($15.3M position)2.3M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | NEUE | Director, 10% owner | Form 4 sale | 3,915 | $26k | 0.2% | No plan | SEC |
| Mar 15, 2023 | COUR | Director | Form 4 sale | 1,226 | $14k | 3.7% | Plan not stated | SEC |
| May 25, 2022 | GENOCEA BIOSCIENCES, INC. | 10% owner | Form 4 sale | 10.4M | $771k | 100.0% | Unusual | SEC |
| Dec 22, 2021 | Metacrine, Inc. | 10% owner | Form 4 sale | 497,270 | $494k | 16.2% | Plan not stated | SEC |
| Apr 3, 2020 | TRVI | 10% owner | Form 4 sale | 564 | $2k | 0.0% | Plan not stated | SEC |